Literature DB >> 25135470

The acute cardiorenal syndrome: burden and mechanisms of disease.

Petra Nijst1, Wilfried Mullens.   

Abstract

Worsening renal function during the treatment of acute decompensated heart failure, so-called acute cardio-renal syndrome, is very common and complicates the treatment course. The underlying pathophysiology of worsening renal function (WRF) involves variable contributions of renal hemodynamics, neurohormonal activity, and oxidative stress. Historically, WRF has been associated with adverse outcomes. However, emerging data support therapeutic strategies that permit WRF while effectively treating congestion as they are associated with improved outcomes.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25135470     DOI： 10.1007/s11897-014-0218-4

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN： 1546-9530


  78 in total

1.  Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function.

Authors:  Marco Metra; Beth Davison; Luca Bettari; Hengrui Sun; Christopher Edwards; Valentina Lazzarini; Barbara Piovanelli; Valentina Carubelli; Silvia Bugatti; Carlo Lombardi; Gad Cotter; Livio Dei Cas
Journal:  Circ Heart Fail       Date:  2011-12-13       Impact factor: 8.790

2.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

3.  Effect of nesiritide in patients with acute decompensated heart failure.

Authors:  C M O'Connor; R C Starling; A F Hernandez; P W Armstrong; K Dickstein; V Hasselblad; G M Heizer; M Komajda; B M Massie; J J V McMurray; M S Nieminen; C J Reist; J L Rouleau; K Swedberg; K F Adams; S D Anker; D Atar; A Battler; R Botero; N R Bohidar; J Butler; N Clausell; R Corbalán; M R Costanzo; U Dahlstrom; L I Deckelbaum; R Diaz; M E Dunlap; J A Ezekowitz; D Feldman; G M Felker; G C Fonarow; D Gennevois; S S Gottlieb; J A Hill; J E Hollander; J G Howlett; M P Hudson; R D Kociol; H Krum; A Laucevicius; W C Levy; G F Méndez; M Metra; S Mittal; B-H Oh; N L Pereira; P Ponikowski; W H W Tang; W H Wilson; S Tanomsup; J R Teerlink; F Triposkiadis; R W Troughton; A A Voors; D J Whellan; F Zannad; R M Califf
Journal:  N Engl J Med       Date:  2011-07-07       Impact factor: 91.245

4.  Intrarenal regulatory factors of salt excretion during renal venous pressure elevation.

Authors:  R L Wathen; E E Selkurt
Journal:  Am J Physiol       Date:  1969-06

Review 5.  Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors.

Authors:  Kim E Jie; Marianne C Verhaar; Maarten-Jan M Cramer; Karien van der Putten; Carlo A J M Gaillard; Pieter A Doevendans; Hein A Koomans; Jaap A Joles; Branko Braam
Journal:  Am J Physiol Renal Physiol       Date:  2006-08-01

Review 6.  The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.

Authors:  Giuseppe Remuzzi; Norberto Perico; Manuel Macia; Piero Ruggenenti
Journal:  Kidney Int Suppl       Date:  2005-12       Impact factor: 10.545

7.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

8.  Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.

Authors:  Roberta Poletti; Giuseppe Vergaro; Luc Zyw; Concetta Prontera; Claudio Passino; Michele Emdin
Journal:  Int J Cardiol       Date:  2012-03-28       Impact factor: 4.164

9.  Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase.

Authors:  B Hornig; U Landmesser; C Kohler; D Ahlersmann; S Spiekermann; A Christoph; H Tatge; H Drexler
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690

Review 10.  Intra-abdominal hypertension in the critically ill: it is time to pay attention.

Authors:  Manu L N G Malbrain; Dries Deeren; Tom J R De Potter
Journal:  Curr Opin Crit Care       Date:  2005-04       Impact factor: 3.687
View more
  8 in total

Review 1.  A multidimensional sight on cardiac failure: uncovered from structural to molecular level.

Authors:  Vijay Urmaliya; Gustavo Franchelli
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

Review 2.  Exercise intervention in hospitalized heart failure patients, with emphasis on congestion-related complications: a review.

Authors:  Jirka Cops; Sibren Haesen; Bart De Moor; Wilfried Mullens; Dominique Hansen
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

3.  Aspirin upregulates αB-Crystallin to protect the myocardium against heat stress in broiler chickens.

Authors:  Shu Tang; Bin Yin; Erbao Song; Hongbo Chen; Yanfen Cheng; Xiaohui Zhang; Endong Bao; Joerg Hartung
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

4.  Selective abdominal venous congestion to investigate cardiorenal interactions in a rat model.

Authors:  Jirka Cops; Wilfried Mullens; Frederik H Verbrugge; Quirine Swennen; Carmen Reynders; Joris Penders; Jean-Michel Rigo; Dominique Hansen
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

5.  Selective abdominal venous congestion induces adverse renal and hepatic morphological and functional alterations despite a preserved cardiac function.

Authors:  Jirka Cops; Wilfried Mullens; Frederik H Verbrugge; Quirine Swennen; Bart De Moor; Carmen Reynders; Joris Penders; Ruth Achten; Ann Driessen; Amélie Dendooven; Jean-Michel Rigo; Dominique Hansen
Journal:  Sci Rep       Date:  2018-12-10       Impact factor: 4.379

6.  Nitric oxide mediated the effects of nebivolol in cardiorenal syndrome.

Authors:  Guldem Mercanoglu; Onder Semen
Journal:  Iran J Basic Med Sci       Date:  2019-11       Impact factor: 2.699

7.  Inhibition of platelet-derived growth factor pathway suppresses tubulointerstitial injury in renal congestion.

Authors:  Takuma Matsuki; Takuo Hirose; Yusuke Ohsaki; Satoshi Shimada; Akari Endo; Hiroki Ito; Chika Takahashi; Seiko Yamakoshi; Ikuko Oba-Yabana; Go Anan; Toshiko Kato; Ryo Tajima; Shingo Nakayama; Tomoyoshi Kimura; Hannah Nakamura; Junichi Tani; Kazuhiro Takahashi; Shigeo Kure; Takefumi Mori
Journal:  J Hypertens       Date:  2022-08-19       Impact factor: 4.776

Review 8.  Renal dysfunction in cardiovascular diseases and its consequences.

Authors:  Giacomo Deferrari; Adriano Cipriani; Edoardo La Porta
Journal:  J Nephrol       Date:  2020-09-01       Impact factor: 3.902
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.